secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2025-03-17T23:59:59+00:00
Accession:  0001654954-25-002892
Event type: earnings
Sentiment:  positive
Materiality: 0.35
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv reports Q1 revenue of $2.5M, near breakeven net income
----------------------------------------------------------------------

- Revenue for quarter ended Jan 31, 2025 was ~$2.5M, up ~$0.1M YoY.
- Net income near breakeven, an increase of ~$0.3M compared to same quarter last year.
- CEO cites net revenue growth in served markets with projects in Europe, Asia, and Latin America.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495425002892/0001654954-25-002892-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495425002892/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-25-002892

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer